Prokidney (PROK) FCF Margin (2024 - 2026)
Prokidney's (PROK) quarterly FCF Margin came in at 29471.33% in Q2 2026, down 1384780.0% year-over-year from N/an in Q2 2025, and down 46.48% quarter-over-quarter from 20119.03% in Q1 2026.
Powered by 
Analysis
Prokidney (PROK) FCF Margin (2024 - 2026) Analysis & Trends
Prokidney (PROK) has reported FCF Margin for 3 consecutive years, with 29471.33% the latest figure, recorded in Q2 2026.
- On a quarterly basis, FCF Margin fell 1384780.0% year-over-year to 29471.33% in Q2 2026; TTM through Jun 2026 was 19527.38%, a 828666.0% increase from a year earlier, with the FY2025 full-year figure at 15152.63%, up 18992632.0% from the prior year.
- FCF Margin was 29471.33% for Q2 2026 at Prokidney, down from 20119.03% in the prior quarter.
- Over five years, FCF Margin peaked at 13359.57% in Q1 2025 and troughed at 65368.42% in Q4 2024.
- A 3-year average of 25085.67% and a median of 17006.67% in 2025 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin jumped 4836175 bps in 2025 and sank 1384780 bps in 2026, its largest moves.
- Over 3 years, FCF Margin stood at 65368.42% in 2024, then jumped by 74 bps to 17006.67% in 2025, then plunged by 73 bps to 29471.33% in 2026.
- The last three FCF Margin figures came in at 29471.33% (Q2 2026), 20119.03% (Q1 2026), and 17006.67% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn | 59.74% |
| 2 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - | -826.50% |
| 3 | Iovance Biotherapeutics | 3.82 Bn | 3.52 Bn | 55.72 Mn | -66.71% |
| 4 | Legend Biotech | 3.67 Bn | 2.71 Bn | 251.50 Mn | -3.46% |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | -497.31% |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | -13,981.63% |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | -33.11% |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 48.98% |
| 9 | Vericel | 1.98 Bn | 1.81 Bn | 56.40 Mn | 18.67% |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | -29,471.33% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29,471.33% |
| Mar 31, 2026 | -20,119.03% |
| Dec 31, 2025 | -17,006.67% |
| Sep 30, 2025 | -14,651.15% |
| Jun 30, 2025 | -15,623.53% |
| Mar 31, 2025 | -13,359.57% |
| Dec 31, 2024 | -65,368.42% |